Amanda Glassman, director of Global Health Policy at the Center for Global Development, discusses the impact of non-communicable diseases (NCDs), strategies to reduce NDC occurence, and the failure to implement such interventions.

Derek Yach, director of global health policy at PepsiCo, discusses the role of government and business in lowering mortality rates from non-communicable diseases (NCDs). "We now have overwhelming evidence, both of the health impact, and perhaps as importantly, we're starting to see the economic impact of heart disease, diabites, chronic lung disease, cancer," says Yach, arguing this data is raising global interest in the issue of NCDs.

Amanda Glassman and Kate McQueston suggest five affordable low-cost or no-cost interventions against the increasing frequency of non-communicable diseases.

Following a screening of Contagion, screenwriter Scott Z. Burns and CFR's Laurie Garrett discuss public fear caused by health threats such as Anthrax and H1N1.

The authors consider how non-communicable disease prevention strategies might be integrated into pre-existing health platforms in order to minimize costs and maximize efficiency.

Sir George Alleyne, Alafia Samuels, and Karen Sealey explain the tensions between advocacy factions in the effort to reduce non-communicable diseases (and communicable diseases), and potential constructive resolutions.

Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, explores the lasting impact of the terrorist attacks of September 11, 2001, and the anthrax attacks that followed on disaster preparedness and health policy in the United States. Garrett argues that "all our readiness response depends on well-funded police, well-funded fire departments, well-funded hospitals, well-funded public health infrastructures, and precisely the opposite is where we are going right now." Garrett cautions that U.S. preparedness for a major terrorist attack may be decreasing. "As budgets are being cut at the federal level, the state level, and the local level, we're actually less ready than we were in 2001," Garrett says.

This roundtable, Crisis in the Horn: Can We Prevent One Million Deaths Today and Worse Famines Tomorrow?, was part of CFR's Global Health program.

Yanzhong Huang discusses the impact of chronic, noncommunicable disease on development in the BRICS nations.

Peter Orszag explains how federal incentives are bringing the digital revolution to U.S. health care.

Tobacco is reemerging as a polarizing issue in U.S. trade policy. New trade agreement negotiations are forcing the White House to choose between the tobacco debate's partisans. This policy innovation memorandum proposes a new strategy by which the Obama administration can better balance U.S. mandates on trade policy on tobacco with its interests in promoting global health and U.S. standing abroad.

The Non-Communicable Diseases Alliance (NCD) released this action plan on noncommunicable diseases in preparation for the United Nations Summit on Non-Communicable Diseases in September 2011.

The World Health Organization (WHO) published this report on the global status of noncommunicable diseases.

The World Health Organization (WHO) published this 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases in 2009.

The World Health Organization (WHO) released this report on women's and children's health in September 2010, launching its Global Strategy for Women's and Children's Health program.

Experts discuss the importance of prevention and control of non-communicable diseases, as well as the need for the United States and the United Nations to play a larger role.

Experts discuss the importance of prevention and control of non-communicable diseases, as well as the need for the United States and the United Nations to play a larger role.

Experts discuss the importance of prevention and control of non-communicable diseases, as well as the need for the United States and the United Nations to play a larger role.